INS and type 2 diabetes mellitus: Moreover, RvD1 treatment has been found to increase levels of activated AMPK in the adipose tissues [45] and to enhance insulin sensitivity via Akt phosphorylation, a downstream target of the insulin signaling pathway [45,50], potentially alleviating type 1 and type 2 diabetes in rats [50,51].